Bio-Techne Corp
TECH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.39B
Close$
$21.61
70.3% downside
Current Fair Value
70.3% downsideOvervalued by 70.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $11.39 Billion |
|---|---|
| Enterprise Value | $11.44 Billion |
| Annual dividend | $0.32 |
| Dividend yield | 0.44% |
| Earnings per Share | $1.17 |
| Beta | 1.3 |
| Outstanding Shares | 155,963,000 |
Return
| Return on Equity | 8.63% |
|---|---|
| Return on Assets | 7.03% |
| Return on Invested Capital | 10.06% |
Valuation & Multiples
| P/E Ratio | 62.1 |
|---|---|
| PEG | -15.19 |
| Price to Sales | 10.39 |
| Price to Book Ratio | 5.59 |
| Enterprise Value to Revenue | 9.42 |
| Enterprise Value to EBIT | 46.93 |
| Enterprise Value to Net Income | 62 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$0.44
Consensus analyst estimateRevenue Estimate
$292.60 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 2, 2027
EPS Estimate
$0.47
Consensus analyst estimateRevenue Estimate
$307.57 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 9.95% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.15%▼ 112.29% |
|---|---|
| Total Invested | $130.37M▼ 98.95% |
| Investors Holding | 141▼ 476.00% |
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth
Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...